Meet the filmmaker documenting his father’s Parkinson’s journey
Author: Pippa Prendergast-CoatesPublished: 9 July 2020
Prep: Cook: Serves:
US filmmaker Robert Cochrane decided to turn the “gut punch” experience of his father’s Parkinson’s diagnosis into a chance to grow their relationship. He tells us how his acclaimed documentary series ‘Boys of Summer’ records their journey with the condition, while travelling to all the baseball parks in America
Can you tell us about your documentary series ‘Boys of Summer’?
‘Boys of Summer’ started as the fulfilment of a promise between my dad and me. We started road-tripping to baseball ballparks in the US in the early 90s as a way of getting to know each other better across a shared interest of the sport. We saw seven parks in two years, then life got busy. We said we’d get back to it but didn’t start thinking about it in earnest until 2001, when my dad was diagnosed with Parkinson’s.
When I rewatched the sports fantasy drama ‘Field of Dreams’ my heart was set afire. I knew I didn’t want the regret of a relationship left unexplored.
Our intention for ‘Boys of Summer’ was to spend a lot of time together, see a lot of the country, all the Major League Baseball parks and meet as many people with or affiliated with Parkinson’s as possible to better understand what our journey with the condition might be like. The Parkinson’s diagnosis, with all its unknowns, added the pressure to say: “this is why we need to do this now”.
How has the series developed?
The project was supposed to be a one-off documentary. When there was no cure, however, and people kept asking me how my dad was doing, we decided to film a follow up in 2014 with ‘Second Base’. Our third documentary ‘Short Stop’ began in 2017, with the desire to pass the baseball torch further to the grandkids and explore more of the best of what was happening in Parkinson’s communities across the country.
We’ve been told our films are inspiring, thought-provoking and important in terms of providing an example of love and empathy in the face of a difficult condition.
How did you feel when you heard about your dad’s diagnosis?
It was a gut punch and felt very scary, especially because I knew so little about it. It also came two weeks after my mum’s diagnosis with breast cancer.
My dad was told point blank he had Parkinson’s and would be in a wheelchair at some point. It could be in six months or 30 years, but this was the future he was advised to prepare for. You could use the term “bleak” to describe the experience.
How has making these documentaries changed your perspective?
I’ve learned many things but maybe the most important ones have to do with the value of time and the infinite depth of relationships, if you’re willing to do the work to dig in. There’s so much more to my relationship with my dad than I imagined – largely because we’ve chosen to say yes to each other’s ideas, adventure together (even when we weren’t sure exactly where we were going or how we’d get there), trusted each other, invested in each other and laughed a lot.
My dad’s favourite part of the process is the interviews. He’s always happy to see people moved and affected by our stories. I’m happy to know I’ve contributed to my dad’s happiness and quality of life – I’m quite sure he’s living better because of what we’ve done.
This work has been a labor of love and completely grassroots the entire way. It’s my hope that this story can be more widely shown and used to inspire and improve quality of life for millions of others.
Is there anything you’ve learned about Parkinson’s that you wish you could share with your younger self?
The general focus regarding how to approach Parkinson’s as a person living with the condition or care partner has changed. In 2004, the rally cry throughout the community was “A cure within 10 years!”. It was a moon shot that never landed, unfortunately. Our shift from cure to quality of life wasn’t an easy one, but it has made the years since better. We now know the power really rests in our hands.
I strongly encourage people to connect and engage with their local Parkinson’s communities because isolation is a killer. Treat exercise like brushing your teeth. And laugh a lot.
Robert Cochrane (left) with his dad
Need to know
Robert Cochrane is a US filmmaker and is a PhD student at the University of Nevada, Las Vegas, US, studying the effect of improvisation on Parkinson’s. He has worked in film for 25 years, credited on 11 films.‘Boys of Summer’ (2006) was the first documentary in a planned series, three of which are now available.
Alongside filmmaking, Robert runs Improv to Improve Parkinson’s disease (i2iPD), an improvisational theatre workshop specifically for people with Parkinson’s. Find out more about i2iPD here.
For more information on the latest Parkinson’s updates please visit the EPDA website.
WPC Scientific Update 2015: the low-down on latest advances
Webcast gives free access to pioneering Parkinson's science
49 mins ago
Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?
A new study suggests that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may lower the risk of Parkinson’s associated with mutations of the LRRK2 gene – a common genetic cause of the condition. As part of the study, researchers analysed the data for 577 individuals with the LRRK2 gene mutation. They found that regular use of aspirin and ibuprofen – at least two pills per week for at least six months – was more prevalent in people who did not have Parkinson’s compared to those with the condition. Across the study, the use of NSAIDs corresponded with roughly a 66% decrease in the risk of Parkinson’s. The researchers say that “the results of this study suggest that the regular use of NSAID medication may lower the risk for Parkinson’s among LRRK2 variant carriers … for both ibuprofen and aspirin” but more research will need to be…
US hospital initiative improves on-time administration of Parkinson’s medication
Late or missed doses of Parkinson’s medication in hospitals can lead to longer stays and greater morbidity. To counteract this issue, a team of healthcare professionals in the US launched a project to improve the on-time administration of levodopa to people with Parkinson’s. As part of the initiative – published in the Journal of Parkinson’s Disease – several measures were implemented, including electronic alerts for nurses, stocking automated medication dispensing machines with carbidopa-levodopa products, reporting to nurse unit managers on timeliness of medication administration and more. Dr Martha A Nance, the project’s lead investigator, said: “This project was very rewarding for our team, because of its obvious, immediate, and important impact on patient care. “We have reason to think that timely administration of carbidopa-levodopa may be associated with shorter stays and better outcomes and satisfaction. Anecdotally, patients have reported being surprised and pleased that nurses were reminding them that medication…
Does deep brain stimulation for Parkinson’s increase the risk of dementia?
Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia. As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia. After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia. Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”